Doctor Emanuele Bertaglia

Doctor Emanuele Bertaglia

Hospital of Camposampiero, Camposampiero (Italy)

Member of:

He was born in Venice (Italy), June 11 1966. In July 1985 he obtained the diploma of Secondary School at the Liceo Scientifico Istituto Cavanis of Venice. In November 1985 he entered the Faculty of Medicine at the University of Padua. He attended the pre-graduation medical training at the Division of Cardiology of the Policlinico Universitario of Padua from May 1990. On the July 24 1991 he was graduated Medical Doctor at the University of Padua (110/110 cum laude). In 1991 he was qualified to the practise of Medicine and Surgery by the State Examing Commision. In 1992 he won the competition for the admission to the Post-graduate Course in cardiology at the University of Padua. On February 03 1997 he obtained the Diploma of Specialist in Cardiology at the University of Padua (70/70 cum laude). On April 27 2016 he obtained the Ph.D. title in Scienze Mediche, Cliniche e Sperimentali curriculum Scienze Cardiovascolari at the University of Padova

Presentations

Is renal dysfunction associated with the outcome of CRT patients?

Event: ESC Congress 2019

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Cardiac resynchronisation therapy

Access

CRT implantation in patients with moderate-to-severe renal dysfunction: results from the CRT-MORE registry

Event: EHRA 2019

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Cardiac Resynchronization Therapy

Access

The VALID-CRT risk score reliably predicts outcome after cardiac resynchronization therapy in an real-world population

Event: EHRA 2018

Topic: Cardiac Resynchronization Therapy

Session: CRT - A room for improvement?

Access

Cardiac resynchronization therapy in elderly: predictors of mortality at 12-months follow-up

Event: EHRA 2018

Topic: Cardiac Resynchronization Therapy

Session: CRT

Access

Doctor Emanuele Bertaglia

Biography

Contributor content

Is renal dysfunction associated with the outcome of CRT patients?

CRT implantation in patients with moderate-to-severe renal dysfunction: results from the CRT-MORE registry

The VALID-CRT risk score reliably predicts outcome after cardiac resynchronization therapy in an real-world population

Cardiac resynchronization therapy in elderly: predictors of mortality at 12-months follow-up

ESC 365 is supported by